ANIX Stock Summary and Trading Ideas (Anixa Biosciences | NASDAQ:ANIX)

Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

Anixa Biosciences trades on the NASDAQ stock market under the symbol ANIX.

As of April 25, 2024, ANIX stock price climbed to $3.27 with 82,771 million shares trading.

ANIX has a beta of 0.79, meaning it tends to be less sensitive to market movements. ANIX has a correlation of 0.02 to the broad based SPY ETF.

ANIX has a market cap of $104.31 million. This is considered a Micro Cap stock.

In the last 3 years, ANIX stock traded as high as $6.45 and as low as $2.30.

The top ETF exchange traded funds that ANIX belongs to (by Net Assets): VTI, VXF, IWC, DFAC.

ANIX has underperformed the market in the last year with a return of -33.3%, while the SPY ETF gained +22.7%. In the last 3 month period, ANIX fell short of the market, returning -31.6%, while SPY returned +3.3%. However, in the most recent 2 weeks ANIX has outperformed the stock market by returning +2.2%, while SPY returned -2.8%.

ANIX support price is $3.05 and resistance is $3.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANIX stock will trade within this expected range on the day.